Anuh Pharma Ltd NSE:ANUHPHR:
ANUH PHARMA LTD - MAHARASHTRA FACILITY UNDERGONE AUDIT BY EDQM
ANUH PHARMA LTD - FACILITIES WERE FOUND TO BE COMPLIANT DURING EDQM AUDIT
Anuh Pharma Says Maharashtra Facility Undergone Audit By EDQM
Story so far
Earlier from Anuh Pharma
- ANUHPHR: Q3 FY26 saw higher revenue, profit, and margins, plus a completed 1: 1 bonus share issue
- Anuh Pharma Granted Certificate Of Suitability From EDQM For Sulfadimethoxine
- ANUHPHR: Revenue increased but net profit fell; bonus shares issued and governance policies updated
- ANUHPHR: Sequential revenue and profit decline offset by year-over-year growth and leadership addition
- ANUHPHR: Net profit declined despite revenue growth; 1: 1 bonus issue and 30% dividend proposed
Later from Anuh Pharma
- ANUHPHR: FY26 revenue rose, but profit and margins declined; bonus shares issued and dividend proposed
- ANUHPHR: FY26 revenue rose 15.66% to ₹776 Cr, driven by exports and regulatory market expansion
Follow Anuh Pharma into a list and get an email when it puts out news.
Follow Anuh Pharma